The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitis

[1]  Hong Wang,et al.  Detection Rate and Antigenic Specificities of Antineutrophil Cytoplasmic Antibodies in Chinese Patients with Clinically Suspected Vasculitis , 2004, Clinical Diagnostic Laboratory Immunology.

[2]  U. Specks,et al.  Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. , 2003, The American journal of medicine.

[3]  V. Tesar,et al.  Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  P. Merkel,et al.  Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. , 2003, Arthritis and rheumatism.

[5]  D. Scott,et al.  Epidemiology of the vasculitides. , 2003, Current opinion in rheumatology.

[6]  L. Kamesh,et al.  ANCA-positive vasculitis. , 2002, Journal of the American Society of Nephrology : JASN.

[7]  R. Luqmani.  Measuring disease activity and outcomes in clinical studies. , 2002, Cleveland Clinic journal of medicine.

[8]  D. Scott,et al.  Epidemiology of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. , 2002, Cleveland Clinic journal of medicine.

[9]  R. Luqmani.  Assessing disease activity in the systemic vasculitides , 2002, Current opinion in rheumatology.

[10]  D. Scott,et al.  Epidemiology of vasculitis in Europe , 2001, Annals of the rheumatic diseases.

[11]  C. Savage.  ANCA-associated renal vasculitis. , 2001, Kidney international.

[12]  G A Colditz,et al.  Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. , 2001, The Journal of rheumatology.

[13]  P. Bacon,et al.  Activity, damage and outcome in systemic vasculitis. , 2001, Best practice & research. Clinical rheumatology.

[14]  B. Cohen,et al.  Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  W. Koldingsnes,et al.  Epidemiology of Wegener's granulomatosis in northern Norway. , 2000, Arthritis and rheumatism.

[16]  D. Scott,et al.  Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. , 2000, Arthritis and rheumatism.

[17]  R J Falk,et al.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) , 1999, American journal of clinical pathology.

[18]  J. Amouroux,et al.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. , 1999, Arthritis and rheumatism.

[19]  P Lesavre,et al.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. , 1998, Kidney international.

[20]  C. Lockwood,et al.  A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. , 1996, Journal of immunological methods.

[21]  C. Kallenberg,et al.  Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. , 1994, Kidney international.

[22]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[23]  M. Zhao,et al.  [The renal involvement of primary vasculitis: clinical and pathological analysis of 5 cases]. , 1993, Zhonghua nei ke za zhi.

[24]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. , 2010, Arthritis and rheumatism.